Another pharma giant targets India derma-cosmetic brands

By Michelle Yeomans contact

- Last updated on GMT

Related tags: Cosmetics, Medicine

Another pharma giant targets India derma-cosmetic brands
Italian pharmaceutical conglomerate Menarini is buying out an established derma-cosmetics product portfolio in an effort to strengthen its operations across various industries in India.  

The Indian subsidiary of the $4.2-billion Menarini Group is said to be in the early stages of discussions with a handful of companies to acquire brands across segments including skin care - it currently sells Johnson & Johnson products.

According to managing director, Girdhar Balwani, the company is looking at acquisitions in the range of Rs 500 crore and that “We are in discussions with some Indian firms, but unreasonable valuation is a constraint.”

"We expect the existing business to grow to Rs 250 crore by 2018; another Rs 250 crore is to come through a combination of OTC business and possible acquisitions​,” the MD adds.

Further investment in the cosmetics area..

In India, Menarini has Hexilak Silicone Gel in the segment for the removal of scars, and is now being considered for the over-the-counter acquisition.

Once we are successful with the OTC promotion of Hexilak Silicon Gel, we would evaluate the scope of taking Acnelak, an anti-acne soap, and Papulex (cream/cleansing gel), and the dermo-cosmetic range for the management of acne​,” Balwani explains.

Currently, Menarini India accounts for about 65 brands acquired and in-licensed from Invida India, ShalaksPharma, MRPL and Sinclair IS Pharma.

Earlier in the year, Invida had acquired the dermatology and primary care brand portfolio from Delhi-based Shalaks Pharmaceuticals. Last year, MRPL was integrated with Invida India; it was rebranded as Menarini India this year.

The company’s projected revenue for 2013 is about Rs 100 crore (80 per cent from brands and 20 per cent from CSO (contract sales organisation).

Pharma companies frequently crossing over  into cosmetics

Elder Pharmaceuticals recently revealed it was teaming up with Japanese cosmetic giant, Kose to develop a personal care range specifically for the Indian market.

At the time Elder stated that the venture was an effort to help both companies hone their skills for the Indian market, where culture and tastes are very different, the Japanese company is said to have considered it essential to undertake strategic and business planning tailored to the region.

Elsewhere, the brothers of Indian firm, Paras Pharmaceuticals announced they were making their way back into the personal care sector with their own cosmetic brands which experts believe will be fierce competition for the consumer goods company, Marico who bought out the brothers back in 2010.

Related news

Show more

Related products

show more

Tagra: Stabilizing Retinol to Rejuvenate Skin

Tagra: Stabilizing Retinol to Rejuvenate Skin

Tagra Biotechnologies | 03-Oct-2022 | Product Presentation

Retinol is widely regarded in the cosmetics industry as a golden ingredient for ageless skin. Yet, it tends to lose its efficacy quickly due to a variety...

Sensiva™ go natural,a protector without compromise

Sensiva™ go natural,a protector without compromise

Ashland Global Holdings Inc | 24-Jun-2022 | Technical / White Paper

Consumers are increasingly buying natural, organic beauty and wellbeing products as noted from the increasing number of product launches with natural claim...

Formulating for Clean Beauty

Formulating for Clean Beauty

Elementis | 26-May-2022 | Product Brochure

Water scarcity and water pollution continues to be a concern for the environment. Every year, about 130 tons of microplastic particles from personal care...

Follow us

Products

View more

Webinars

Indie Pioneers Podcast

Indie Pioneers Podcast